EW

Edwards Lifesciences Corporation

November 4, 2026 · after-hours

Rarity

1.65

Peak move

+5.71%

Float cap

$56.9B

Still running — rarity and peak move can only rise from here.

Edwards Lifesciences Corporation develops and sells medical technologies for structural heart disease. Its portfolio includes transcatheter aortic valve replacement, transcatheter mitral and tricuspid therapies, and surgical heart valves and repair products. These therapies are used by cardiac surgeons and interventional cardiologists to treat patients with aortic, mitral, tricuspid, and pulmonic valve disease and other advanced cardiovascular conditions.